SENATE ADOPTS HATCH MDR PRODUCT LIABILITY PROTECTION UNDER FDA REFORM BILL
This article was originally published in The Gray Sheet
Manufacturers would be protected from the presumption that an adverse event report to FDA represents an acknowledgment of liability under an amendment added to the Senate FDA reform bill (S 830) prior to passage of the bill Sept. 24.
You may also be interested in...
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.
A medtech industry group is asking the Trump administration to clarify if small medical device companies that have equity investors qualify for small business loans and forgiveness under the coronavirus relief package.
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.